Results 161 to 170 of about 10,858 (213)
Longitudinal changes in estimated glomerular filtration rates in chronic hepatitis B patients treated with Tenofovir Alafenamide <i>vs</i> Entecavir. [PDF]
Li X +8 more
europepmc +1 more source
Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV. [PDF]
Daar ES +13 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annals of Pharmacotherapy, 2016
Objective: To review the pharmacology, efficacy, safety, and place in therapy for tenofovir alafenamide (TAF). Data Sources: A search using PubMed was conducted (2004 to May 2016) using the following keywords: tenofovir alafenamide, TAF, and GS-7340. Articles were evaluated for content, and bibliographies were reviewed.
Amanda K. Gibson +3 more
openaire +2 more sources
Objective: To review the pharmacology, efficacy, safety, and place in therapy for tenofovir alafenamide (TAF). Data Sources: A search using PubMed was conducted (2004 to May 2016) using the following keywords: tenofovir alafenamide, TAF, and GS-7340. Articles were evaluated for content, and bibliographies were reviewed.
Amanda K. Gibson +3 more
openaire +2 more sources

